The RIO trial: A Randomised Placebo-Controlled Study of
2 LS-bNAbs (3BNC-117-LS & 10-1074-LS) in People Treated in Early HIV
CROI 2025 SF March 9-12
S. Fidler, M. Lee, S. Collins, L. Cherrill, E. Falaschetti, P. Zacharopoulou, M. Altaf, T. Tipoe, G. Taylor, M. Fumagalli, G. Tomaras, M. Caskey, M. Nussenzweig, J. Frater and the RIO Trial Investigators
